
    
      ASTUTE is a longitudinal, randomised, multicentre, and multinational pragmatic study of
      patients with Chronic Obstructive Pulmonary Disease to evaluate the comparative effectiveness
      of Aclidinium bromide/formoterol fumarate fixed-dose combination (Duaklir™ Genuair®) and
      Standard of Care bronchodilators in patients treated with long acting bronchodilator
      monotherapies OR patients who abide to the following treatment category: patient is newly
      diagnosed, or naïve to maintenance therapy, or treated with short-acting bronchodilators as
      rescue medication, or has not been treated with long-acting bronchodilators in the last 3
      months.
    
  